CN1846773A - Bladder cancer treating Chinese medicine prepn - Google Patents
Bladder cancer treating Chinese medicine prepn Download PDFInfo
- Publication number
- CN1846773A CN1846773A CN 200610057952 CN200610057952A CN1846773A CN 1846773 A CN1846773 A CN 1846773A CN 200610057952 CN200610057952 CN 200610057952 CN 200610057952 A CN200610057952 A CN 200610057952A CN 1846773 A CN1846773 A CN 1846773A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- portions
- bladder cancer
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to bladder cancer treating Chinese medicine preparation. The Chinese medicine preparation is prepared with 15 kinds of Chinese medicinal materials, including Japanese felt fern frond, astragalus root, patrinia, black nightshade, cattail pollen, etc. It has the functions of clearing away heat and toxic material, promoting diuresis, treating stranguria, benefiting Qi, invigorating spleen, resisting cancer and dispersing obstruction. It is used to treat bladder cancer mainly and has determined curative effect and no toxic side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of bladder cancer, is that a kind of bladder cancer for the treatment of is the Chinese patent medicine of raw material with the Chinese herbal medicine.Belong to the field of Chinese medicines.
Background technology
Bladder cancer is the modal malignant tumor of genitourinary system, and is higher in developed country or regional sickness rate.The sickness rate of tumor of bladder is only second to carcinoma of prostate and belongs to second in the male genitourinary system tumor abroad, then ranks first at home, and the trend of increase is arranged again in recent years.3～4 times of the about women of male's sickness rate, the age was many with 50～70 years old, the patient below 30 is rarer.The modal first symptom of clinical manifestation is a hematuria, and majority is a gross hematuria, urinates based on the painless property of intermittence whole blood.Therefore hematuria is the classical symptom of bladder cancer, accounts for 94% of bladder cancer patients.Secondly clinical manifestation has irritations sign of bladder such as frequent micturition, urgent micturition, dysurea, and this also points out the probability of bladder carcinoma in situ bigger.What frequent micturition, symptoms of urgency were arranged clinically accounts for 8%, and dysurea person accounts for 5%, and the persistence micturition desire can occur, symptoms such as persistence waist distending pain.Once more, clinical manifestation also has dysuria, and last urinary tract blocks, even symptom such as urine retention can occur.According to the study, the cause of disease of bladder cancer is relevant with the chemical carcinogen effect, and as ortho-aminotoluene, aniline etc., benzidine and 2-naphthylamine are confirmed as special BC.Many sick comparative studies show that occupational cancer risks such as dyestuff, rubber, leather are bigger.In addition, gathering and prolonged and repeated effect of harmful substance can cause tumor of bladder.Additional information has been affirmed the relation of smoking and bladder cancer.The pathological classification of bladder cancer often can be divided into transitional epithelium cancer (comprising cancer in situ, papillary carcinoma, infiltrating cancer), squamous cell carcinoma and adenocarcinoma etc.At present, the traditional approach of western medical treatment bladder cancer is operation, chemotherapy, radiotherapy immunization therapy, though can play the effect that suppresses tumor and improve life quality, to recurrence, diffusion and the transfer of bladder cancer, still feels simply helpless.
Bladder cancer belongs to categories such as " hematuria " in the Chinese medicine, " hematuria ", " stranguria with blood ", " difficulty in urination ".Its pathogeny is to move in small intestinal or damp-heat flowing down to the urinary bladder owing to heart-fire is descending; Or be that the disturbance in functioning of QI of suffering from a deficiency of the kidney, water-damp not being transformed, the stasis of blood amass poison, hinder due to the bladder.Clinically often be divided into type Coryza Treated by Syndrome Differentiation such as damp invasion of lower energizer, stagnation of blood stasis, hyperactivity of fire caused by deficiency of YIN, lung-heat with QI-obstruction, deficiency-weakness of spleen-QI, stagnation of QI due to depression of the liver, deficiency of kidney-QI be weak.Traditional Chinese medical science decoction is taken inconvenience, and is relatively poor to the tumor specific aim, and the Chinese and Western patent medicine of determined curative effect seldom.
Summary of the invention
The purpose of this invention is to provide a kind of determined curative effect, safe ready, little, the cheap pure Chinese medicinal preparation of side effect.The present invention is on the basis of secret prescription handed down in the family from generation to generation, in conjunction with the latest modern technological scientific achievement, and under the guidance of the Basic Theories of Chinese Medicine and the principles of formulating prescriptions, develop through repeatedly clinical practice.
The present invention is made by the following weight proportion raw material:
100～400 parts of 150～600 parts of Herba Patriniae of 100～400 parts of Radixs Astragali of Folium Pyrrosiae
75～300 parts of 50～200 parts of Rhizoma Smilacis Glabraes of 75～300 parts of Pollen Typhaes of Herba Solani Nigri
25～100 parts of 150～600 parts of Fructus Foeniculi of 50～200 portions of Herba Lysimachiaes of succinum
50～200 parts of 50～200 parts of Spora Lygodii of 50～200 portions of Semen Plantaginiss of the Radix Linderae
15～60 parts of 50～200 portions of Radix Notoginseng of 75～300 parts of Rhizoma Atractylodis Macrocephalaes of Herba Dianthi
The weight proportion of each raw material of formula optimization of the present invention is:
150～250 parts of 250～350 parts of Herba Patriniae of 150～250 parts of Radixs Astragali of Folium Pyrrosiae
100～200 parts of 80～120 parts of Rhizoma Smilacis Glabraes of 100～200 parts of Pollen Typhaes of Herba Solani Nigri
10～60 parts of 250～350 parts of Fructus Foeniculi of 80～120 portions of Herba Lysimachiaes of succinum
80～120 parts of 80～120 parts of Spora Lygodii of 80～120 portions of Semen Plantaginiss of the Radix Linderae
20～40 parts of 80～120 portions of Radix Notoginseng of 100～200 parts of Rhizoma Atractylodis Macrocephalaes of Herba Dianthi
The weight proportion of best each raw material of prescription of the present invention is:
200 parts of 300 parts of Herba Patriniae of 200 parts of Radixs Astragali of Folium Pyrrosiae
150 parts of 100 parts of Rhizoma Smilacis Glabraes of 150 parts of Pollen Typhaes of Herba Solani Nigri
50 parts of 300 parts of Fructus Foeniculi of 100 portions of Herba Lysimachiaes of succinum
100 parts of 100 parts of Spora Lygodii of 100 portions of Semen Plantaginiss of the Radix Linderae
30 parts of 100 portions of Radix Notoginseng of 150 parts of Rhizoma Atractylodis Macrocephalaes of Herba Dianthi
Drug action mechanism among the present invention is as follows:
The Folium Pyrrosiae nature and flavor are sweet, bitter, be slightly cold.Return lung, urinary bladder channel.Have relieving stranguria by diuresis, preventing phlegm from forming and stopping coughing, lung heat clearing is purged heat, the effect of clearing away heat to stop bleeding.Be used for pyretic stranguria, stranguria with blood, stranguria caused by urinary stone, urinary obstruction, drench the puckery pain of drop, spit blood epistaxis, hematuria, metrorrhagia, cough due to lung-heat.Can control pulmonary carcinoma, tumor of bladder, incised wound, carbuncle etc.Radix Astragali nature and flavor are sweet, warm.Return lung, spleen channel.Have benefit and defend consolidating superficial resistance, diuretic sterilization, poison holding, the effect of granulation promoting.Can control various tumor deficient syndromes, can improve the reticuloendothelial system phagocytic function, and control primary hepatocarcinoma, gastric cancer, the esophageal carcinoma, bladder cancer etc.Herba Patriniae nature and flavor hardship, flat.Return liver, stomach, large intestine channel.Effect with heat-clearing and toxic substances removing, evacuation of pus removing blood stasis with potent drugs.Cure mainly bladder cancer, chorionic epithelioma, cervical cancer, breast carcinoma, laryngeal carcinoma, acute appendicitis, dysentery, leucorrhea with red and white discharge, puerperal be retarded by silt stomachache, conjunctival congestion and swelling pain, carbuncle scabies, appendicitis, enteritis, eye conjunctivitis etc.Herba Solani Nigri nature and flavor hardship, cold.Return lung, stomach, urinary bladder channel.Have heat-clearing and toxic substances removing, invigorate blood circulation, the repercussive effect.Be widely used in various tumors, as cervical cancer, gastric cancer, breast carcinoma, hepatocarcinoma, pulmonary carcinoma, the esophageal carcinoma, bladder cancer, cancerous ascites pleural fluid.The succinum nature and flavor are sweet, flat.Go into the heart, liver, small intestine meridian.Has tranquillizing the mind by relieving convulsion, dissipating blood stasis hemostasis, the effect of relieving stranguria by diuresis.Cure mainly and stop stasis of blood stomachache, skin sore, traumatic injury etc. in bladder cancer, nasopharyngeal carcinoma, rectal cancer, infantile convulsion epilepsy, palpitation with fear insomnia, stranguria with blood hematuria, urinary obstruction, women's amenorrhea, puerperal.The Pollen Typhae nature and flavor are sweet, flat.Return liver, pericardium channel.Have blood circulation promoting and blood stasis dispelling, cooling blood for hemostasis, treating stranguria effect.Be used for hepatocarcinoma, bladder cancer, kidney tumor of ureter, skin carcinoma, gastric cancer, chorionic epithelioma, tonsil squamous cell carcinoma etc.The Rhizoma Smilacis Glabrae nature and flavor are sweet, light, flat.Return liver, stomach warp.Have heat-clearing and toxic substances removing, wind-damp dispelling, bone and muscle strengthening, sharp joint, anticancer.Be used for digestive tract tumor, malignant lymphoma, bladder cancer, cervical cancer, thyroid tumor etc.The Herba Lysimachiae nature and flavor are sweet, salty, be slightly cold.Return liver, gallbladder, kidney urinary bladder channel.Have clearing away heat-damp and promoting diuresis, treating stranguria, repercussive effect.Treating the liver cancer, bladder cancer, pyretic stranguria, huskyly drench, urine is puckeryly had a pain, jaundice dark coloured urine etc.The Spora Lygodii nature and flavor are sweet, light, cold.Return bladder, small intestine meridian.Effect with heat-clearing and toxic substances removing, relieving stranguria by diuresis.Control bladder cancer, hepatocarcinoma, urinary tract infection, lithangiuria, nebulousurine etc.Radix Linderae nature and flavor suffering, temperature.Return spleen, lung, kidney, urinary bladder channel.Have promoting the circulation of QI for relieving swelling, resolving depression pain relieving, the effect of warming spleen and stomach for dispelling cold.Control gastric cancer, intestinal cancer, bladder cancer etc.Herba Dianthi nature and flavor hardship, cold.GUIXIN, small intestinal, kidney, urinary bladder channel.Has the effect that relieving stranguria by diuresis, removing blood stasis stimulate the menstrual flow.Be used for the esophageal carcinoma, rectal cancer, carcinoma of corpus uteri, bladder cancer, gastric cancer etc.Rhizoma Atractylodis Macrocephalae nature and flavor hardship, sweet, warm.Return spleen, stomach warp.Have invigorating the spleen and replenishing QI, the dampness diuresis and in antiabortive, strengthening superficial resistance to stop perspiration, anticancer effect.Can control pulmonary carcinoma, gastric cancer, cervical cancer, osteoma cancer etc.The Semen Plantaginis nature and flavor are sweet, be slightly cold.Return liver, kidney, lung, small intestinal, urinary bladder channel.Has clearing away heat and promoting diuresis, eliminating dampness by diuresis antidiarrheal, liver heat removing and eyesight improving, the effect of removing heat from the lung and dissipating phlegm.Sweet, the little hardship of Radix Notoginseng nature and flavor, temperature.Return liver, stomach, large intestine channel.Has the dissipating blood stasis hemostasis, the effect of subduing swelling and relieving pain.
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", is monarch with Folium Pyrrosiae, Herba Patriniae, Herba Solani Nigri, Herba Lysimachiae, Spora Lygodii, Herba Dianthi and succinum; Pollen Typhae, Radix Notoginseng, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae and Rhizoma Smilacis Glabrae are minister; Fructus Foeniculi, the Radix Linderae are assistant; Semen Plantaginis is for making.All medicines are harmonious, and are total to the tool heat-clearing and toxic substances removing, relieving stranguria by diuresis, replenishing QI to invigorate the spleen, the effect of anticancer dispersing.Treatment bladder cancer determined curative effect has no side effect, and taking convenience is cheap.
The present invention can be made into capsule, preparation method is to get succinum earlier, Fructus Foeniculi and notoginseng drying are crushed to 120～200 order fine powders, get Folium Pyrrosiae again, the Radix Astragali, Herba Patriniae, Herba Solani Nigri, Pollen Typhae, Rhizoma Smilacis Glabrae, Herba Lysimachiae, Spora Lygodii, the Radix Linderae, Herba Dianthi, the Rhizoma Atractylodis Macrocephalae and Semen Plantaginis decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, and the clear paste of relative density 1.08～1.10 adds ethanol and makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, the leaching supernatant reclaims ethanol, is concentrated into the clear paste of relative density 1.30～1.32 when 50 degree～55 are spent, again with clear paste and succinum, Fructus Foeniculi and Radix Notoginseng fine powder mixing, drying is ground into fine powder, incapsulates.Adorn 0.3 gram for every, usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～18, three to four times on the one.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment bladder cancer of the Chinese medicine of respectively distinguishing the flavor of, and does not have chemical sweeting agent, and is nontoxic to human body.Show that through animal acute toxicity experiment the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and mice is 40g crude drug/kg to the maximum tolerated dose of medicine of the present invention, is 150 times of clinical people's consumption, and safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, rich in proteins in the medicine, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid, also contain various trace elements such as Saponin, plant sterol and calcium, be beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention can effectively treat and control bladder cancer, alleviate or eliminate put, the toxic and side effects of chemotherapy, for the early and middle portion bladder cancer patients higher healing rehabilitation efficacy is arranged, for late period bladder cancer patients improved its life quality and time greatly.
Further specify the therapeutic effect of the present invention below by the clinical practice example to bladder cancer.
One, diagnosis of bladder cancer main points: the painless hematuria that unknown cause 1, occurs.2, more than 40 one full year of life of age.3, routine urianlysis prompting hematuria exists.4, KUB (kidney ureter bladder) and intravenous urography are got rid of outer renal pelvis and ureteral tumor.5, cystoscopy and biopsy, clear and definite tumor cell exists.
Two, the curative effect judging standard of Chinese herbal treatment malignant tumor (748 pages of the big Zhang Limin chief editor of " tumor Chinese and western medicine Comprehensive Treatment " old generation People's Health Publisher front pages in July calendar year 2001) () is cured: symptom, the complete obiteration of objective determination positive sign, recover certain work capacity, observe continuously more than 3 years and do not have the recidivist; (2) clinical cure: the positive sign of symptom and objective determination disappears, and recovers certain work capacity; 1 grade: observing continuously more than 1 year does not have the recidivist; 2 grades: observe year no recidivist half a year to 1 continuously; 3 grades: observe 2-6 month no recidivist continuously.(3) produce effects: symptom disappears substantially, and cancer dwindles over half, and other objective determinations take an evident turn for the better; Observe more than half a year no longer development person for 1 grade; 2 grades: observe 2-6 month no longer development person.(4) effective: symptom makes moderate progress, and focus is basicly stable, observes person more than 1 month; (5) invalid: symptom and objective determination do not have improvement, or only have short-term to improve, and deterioration person rapidly.
Three, the clinical observation on the therapeutic effect result is as follows:
Through clinical observation treatment bladder cancer patients 28 examples, male's 20 examples wherein, women's 8 examples.Early stage patient (Tis, T1) 6 examples wherein, mid-term (T2, T3) 8 examples, late period (T4) 14 examples.Take the Chinese medicinal capsule of making by embodiment 1 method, each 2-18 grain (adjusting dosage according to the conditions of patients weight and to the sensitivity of medicine) every day three to four times, take half an hour ante cibum, and eliminating cold for resuscitation water send down.Part patient cooperates chemicotherapy and Chinese medicine Coryza Treated by Syndrome Differentiation, and three months is a course of treatment, takes observe the curative effect after two courses of treatment continuously.Healing, clinical cure (1 grade, 2 grades, 3 grades) 8 examples account for 32.1%, and produce effects (1 grade, 2 grades) 11 examples account for 39.3%, and effective 5 examples account for 17.8%, and invalid 3 examples account for 10.7%, total effective rate 89.7%.
The specific embodiment
Embodiment 1: take by weighing raw material by following proportioning:
200 parts of 300 parts of Herba Patriniae of 200 parts of Radixs Astragali of Folium Pyrrosiae
150 parts of 100 parts of Rhizoma Smilacis Glabraes of 150 parts of Pollen Typhaes of Herba Solani Nigri
50 parts of 300 parts of Fructus Foeniculi of 100 portions of Herba Lysimachiaes of succinum
100 parts of 100 parts of Spora Lygodii of 100 portions of Semen Plantaginiss of the Radix Linderae
30 parts of 100 portions of Radix Notoginseng of 150 parts of Rhizoma Atractylodis Macrocephalaes of Herba Dianthi
Manufacture method is as follows: get succinum earlier, Fructus Foeniculi and notoginseng drying are crushed to 120～200 order fine powders, get Folium Pyrrosiae again, the Radix Astragali, Herba Patriniae, Herba Solani Nigri, Pollen Typhae, Rhizoma Smilacis Glabrae, Herba Lysimachiae, Spora Lygodii, the Radix Linderae, Herba Dianthi, the Rhizoma Atractylodis Macrocephalae and Semen Plantaginis decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill the leaching supernatant 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and succinum, Fructus Foeniculi and Radix Notoginseng fine powder mixing, drying, be ground into fine powder, incapsulate.Adorn 0.3 gram for every, usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～18, three to four times on the one.
Embodiment 2: take by weighing raw material by following proportioning:
400 parts of 600 parts of Herba Patriniae of 400 parts of Radixs Astragali of Folium Pyrrosiae
300 parts of 200 parts of Rhizoma Smilacis Glabraes of 300 parts of Pollen Typhaes of Herba Solani Nigri
100 parts of 600 parts of Fructus Foeniculi of 200 portions of Herba Lysimachiaes of succinum
200 parts of 200 parts of Spora Lygodii of 200 portions of Semen Plantaginiss of the Radix Linderae
60 parts of 200 portions of Radix Notoginseng of 300 parts of Rhizoma Atractylodis Macrocephalaes of Herba Dianthi
Manufacture method is as follows: get succinum earlier, Fructus Foeniculi and notoginseng drying are crushed to 120～200 order fine powders, get Folium Pyrrosiae again, the Radix Astragali, Herba Patriniae, Herba Solani Nigri, Pollen Typhae, Rhizoma Smilacis Glabrae, Herba Lysimachiae, Spora Lygodii, the Radix Linderae, Herba Dianthi, the Rhizoma Atractylodis Macrocephalae and Semen Plantaginis decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill the leaching supernatant 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and succinum, Fructus Foeniculi and Radix Notoginseng fine powder mixing, drying, be ground into fine powder, incapsulate.Adorn 0.3 gram for every, usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～18, three to four times on the one.
Embodiment 3: take by weighing raw material by following proportioning:
100 parts of 150 parts of Herba Patriniae of 100 parts of Radixs Astragali of Folium Pyrrosiae
75 parts of 50 parts of Rhizoma Smilacis Glabraes of 75 parts of Pollen Typhaes of Herba Solani Nigri
25 parts of 150 parts of Fructus Foeniculi of 50 portions of Herba Lysimachiaes of succinum
50 parts of 50 parts of Spora Lygodii of 50 portions of Semen Plantaginiss of the Radix Linderae
15 parts of 50 portions of Radix Notoginseng of 75 parts of Rhizoma Atractylodis Macrocephalaes of Herba Dianthi
Manufacture method is as follows: get succinum earlier, Fructus Foeniculi and notoginseng drying are crushed to 120～200 order fine powders, get Folium Pyrrosiae again, the Radix Astragali, Herba Patriniae, Herba Solani Nigri, Pollen Typhae, Rhizoma Smilacis Glabrae, Herba Lysimachiae, Spora Lygodii, the Radix Linderae, Herba Dianthi, the Rhizoma Atractylodis Macrocephalae and Semen Plantaginis decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill the leaching supernatant 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and succinum, Fructus Foeniculi and Radix Notoginseng fine powder mixing, drying, be ground into fine powder, incapsulate.Adorn 0.3 gram for every, usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～18, three to four times on the one.
Claims (3)
1, a kind of Chinese medicine preparation for the treatment of bladder cancer.It is characterized in that it is made by the following weight proportion raw material:
100～400 parts of 150～600 parts of Herba Patriniae of 100～400 parts of Radixs Astragali of Folium Pyrrosiae
75～300 parts of 50～200 parts of Rhizoma Smilacis Glabraes of 75～300 parts of Pollen Typhaes of Herba Solani Nigri
25～100 parts of 150～600 parts of Fructus Foeniculi of 50～200 portions of Herba Lysimachiaes of succinum
50～200 parts of 50～200 parts of Spora Lygodii of 50～200 portions of Semen Plantaginiss of the Radix Linderae
15～60 parts of 50～200 portions of Radix Notoginseng of 75～300 parts of Rhizoma Atractylodis Macrocephalaes of Herba Dianthi
2, a kind of Chinese medicine preparation for the treatment of bladder cancer according to claim 1, wherein the weight proportion of each raw material is:
150～250 parts of 250～350 parts of Herba Patriniae of 150～250 parts of Radixs Astragali of Folium Pyrrosiae
100～200 parts of 80～120 parts of Rhizoma Smilacis Glabraes of 100～200 parts of Pollen Typhaes of Herba Solani Nigri
10～60 parts of 250～350 parts of Fructus Foeniculi of 80～120 portions of Herba Lysimachiaes of succinum
80～120 parts of 80～120 parts of Spora Lygodii of 80～120 portions of Semen Plantaginiss of the Radix Linderae
20～40 parts of 80～120 portions of Radix Notoginseng of 100～200 parts of Rhizoma Atractylodis Macrocephalaes of Herba Dianthi
3, a kind of Chinese medicine preparation for the treatment of bladder cancer according to claim 1, wherein the weight proportion of each raw material is:
200 parts of 300 parts of Herba Patriniae of 200 parts of Radixs Astragali of Folium Pyrrosiae
150 parts of 100 parts of Rhizoma Smilacis Glabraes of 150 parts of Pollen Typhaes of Herba Solani Nigri
50 parts of 300 parts of Fructus Foeniculi of 100 portions of Herba Lysimachiaes of succinum
100 parts of 100 parts of Spora Lygodii of 100 portions of Semen Plantaginiss of the Radix Linderae
30 parts of 100 portions of Radix Notoginseng of 150 parts of Rhizoma Atractylodis Macrocephalaes of Herba Dianthi
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100579522A CN100382829C (en) | 2006-03-01 | 2006-03-01 | Bladder cancer treating Chinese medicine prepn |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100579522A CN100382829C (en) | 2006-03-01 | 2006-03-01 | Bladder cancer treating Chinese medicine prepn |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1846773A true CN1846773A (en) | 2006-10-18 |
| CN100382829C CN100382829C (en) | 2008-04-23 |
Family
ID=37076654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100579522A Expired - Fee Related CN100382829C (en) | 2006-03-01 | 2006-03-01 | Bladder cancer treating Chinese medicine prepn |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100382829C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101564422B (en) * | 2008-04-23 | 2011-04-20 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating diabetic gout |
| CN104688952A (en) * | 2015-03-29 | 2015-06-10 | 陈彬 | Traditional Chinese medicine composition for treating damp-heat type bladder cancer and preparing method thereof |
| CN104971248A (en) * | 2015-07-10 | 2015-10-14 | 英丽华 | Medicine for treating carcinoma of urinary bladder |
| CN109512936A (en) * | 2017-09-18 | 2019-03-26 | 曾令元 | A kind of herbal composite that treating bladder cancer and preparation method |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMN20000013A1 (en) * | 2000-03-10 | 2001-09-10 | Amfag Spa | REMOVABLE SHOWER FOR KITCHEN |
| CN1522733A (en) * | 2003-09-09 | 2004-08-25 | 王秋如 | Traditional Chinese medicine liquid for treating calculus |
| CN1255148C (en) * | 2003-12-26 | 2006-05-10 | 喻建平 | Chinese medicine for treating urolithiasis and its preparing method |
-
2006
- 2006-03-01 CN CNB2006100579522A patent/CN100382829C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101564422B (en) * | 2008-04-23 | 2011-04-20 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating diabetic gout |
| CN104688952A (en) * | 2015-03-29 | 2015-06-10 | 陈彬 | Traditional Chinese medicine composition for treating damp-heat type bladder cancer and preparing method thereof |
| CN104971248A (en) * | 2015-07-10 | 2015-10-14 | 英丽华 | Medicine for treating carcinoma of urinary bladder |
| CN109512936A (en) * | 2017-09-18 | 2019-03-26 | 曾令元 | A kind of herbal composite that treating bladder cancer and preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100382829C (en) | 2008-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN100382829C (en) | Bladder cancer treating Chinese medicine prepn | |
| CN102626508B (en) | Traditional Chinese medicine composite for curing liver cancer | |
| CN101897933B (en) | Chinese patent medicament for treating leucoderma | |
| CN110339276A (en) | Traditional Chinese medicine for treating digestive tract tumor and preparation method thereof | |
| CN105213807A (en) | Be used for the treatment of the medicine of type of hyperactivity of fire caused by deficiency of YIN recurrent oral ulceration | |
| CN101700390B (en) | Oral traditional Chinese medicine composition for treating fatty liver | |
| CN1109553C (en) | Chinese-medicinal capsule for treating diabetes | |
| CN103720980A (en) | Medicine for treating chronic nephritis | |
| CN1264540C (en) | Acute icterohepatitis treating Chinese traditional medicine and its preparation | |
| CN103386055B (en) | Qianlieantong capsule and preparation method thereof | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN1958028A (en) | Preparation of Chinese traditional medicine for treating hyperplasia of prostate | |
| CN101028349A (en) | Externally-applied medicine for treating prostatitis and prostatic accrementition | |
| CN111407872A (en) | Traditional Chinese medicine composition for treating liver cancer, medicine for treating liver cancer and preparation method of medicine | |
| CN104825817A (en) | Traditional Chinese medicine preparation with antitumor effect | |
| CN1422641A (en) | Medicine for treating cancerous thoracoascites and preparation method | |
| CN1308024C (en) | Medicine for treating diabetes and its preparing method | |
| CN103977276A (en) | Traditional Chinese medicine capsule used for treating radiocystitis | |
| CN1544019A (en) | Chinese traditional medicine composition for treating arthralgia syndrome of cervical spondylopathy and its preparation | |
| CN1287836C (en) | Chinese medicinal powder for treating diabetes and its production method | |
| CN1709298A (en) | Chinese medicine formulation for treating chronic prostatitis and its preparing method | |
| CN101095759B (en) | Medicine that is coated on the navel for treating constipation | |
| CN100998752A (en) | Traditional Chinese medicine decoction for treating radioactive stomatitis | |
| CN100333777C (en) | Medicine for improving enterogastric function after radiation chemiotherapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080423 Termination date: 20110301 |